MAM
Srikanth Raman joins Starcom as media director
MUMBAI: It has been a brief tenure to say the least for Srikant Raman at Triton Communications. Raman joins Starcom Worldwide’s Mumbai office tomorrow as media director.
Raman, who was with Triton for barely two months as media director, was one among quite a few departures from Carat after CEO Meenakshi Madhvani left the company.
One of the key accounts that Raman is expected to look after at Starcom is that of the public sector giant Indian Oil Corporation (IOC). It was in June that Leo Burnett India bagged the integrated “full service” advertising account of IOC. Leo Burnett handles the creative and client servicing functions whereas Starcom manages the centralised media planning and buying. Raman has some experience of working with IOC as it was an account he looked after when he was at Mudra.
Talking about the move Raman says: “Triton is a great place but the short stint is unfortunate. I suppose the timing was slightly wrong and other factors such as Starcom bagging the account of Indian Oil Corporation were responsible for my decision to shift. I am looking forward to joining Starcom as the media agency is doing some great things. Working with the young and dynamic team at Starcom is bound to be a great experience.”
So the hirings at Starcom continue, with more announcements expected.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
